Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients

Transplant Proc. 2001 Feb-Mar;33(1-2):1727. doi: 10.1016/s0041-1345(00)02824-4.

Authors

E P Molmenti¹, D Nagata, J Roden, R Squires, H Molmenti, D Casey, C Fasola, M J Lopez, N Winick, W McPhail, L D'Amico, R Goldstein, M Levy, C Fasola, J Andersen, G Klintmalm

Affiliation

¹ Baylor University Medical Center, Children's Medical Center of Dallas, Dallas, Texas, USA.

PMID: 11267487
DOI: 10.1016/s0041-1345(00)02824-4

No abstract available

MeSH terms

Adolescent
Child
Child, Preschool
Cyclosporine / therapeutic use
Female
Humans
Immunosuppressive Agents / therapeutic use
Incidence
Infant
Liver Transplantation*
Lymphoproliferative Disorders* / diagnosis
Lymphoproliferative Disorders* / epidemiology
Lymphoproliferative Disorders* / therapy
Male
Postoperative Complications* / diagnosis
Postoperative Complications* / epidemiology
Postoperative Complications* / therapy
Tacrolimus / therapeutic use
Treatment Outcome

Substances

Immunosuppressive Agents
Cyclosporine
Tacrolimus